J N Cormier
Overview
Explore the profile of J N Cormier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
750
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cromwell K, Chiang Y, Armer J, Heppner P, Mungovan K, Ross M, et al.
Eur J Cancer Care (Engl)
. 2015 Mar;
24(5):724-33.
PMID: 25809989
We assessed the impact of lymphoedema (defined as ≥ 10% limb volume change) on quality of life (QOL), ability to perform activities of daily living (ADLs) and coping in 277...
2.
Deng J, Fu M, Armer J, Cormier J, Radina E, Thiadens S, et al.
Lymphology
. 2014 Aug;
46(4):173-83.
PMID: 25141460
Currently, a limited number of studies have been conducted that examine sources of information and knowledge level in individuals with lymphedema. This study aimed (1) to examine self-reported information sources...
3.
Stout N, Weiss R, Feldman J, Stewart B, Armer J, Cormier J, et al.
Lymphology
. 2013 Aug;
46(1):27-41.
PMID: 23930439
A project of the American Lymphedema Framework Project (ALFP), this review seeks to examine the policy and economic impact of caring for patients with lymphedema, a common side effect of...
4.
Ridner S, Deng J, Fu M, Radina E, Thiadens S, Weiss J, et al.
Lymphology
. 2013 Jan;
45(3):113-23.
PMID: 23342931
Currently, there is a lack of data related to differences in symptoms and infection across different types and anatomical sites of lymphedema. The objective of this study was to examine...
5.
Feldman J, Stout N, Wanchai A, Stewart B, Cormier J, Armer J
Lymphology
. 2012 Jul;
45(1):13-25.
PMID: 22768469
Intermittent pneumatic compression (IPC) therapy is an effective modality to reduce the volume of the lymphedematous limbs alone or in conjunction with other modalities of therapy such as decongestive therapy....
6.
Cormier J, Xing Y, Zaniletti I, Askew R, Stewart B, Armer J
Lymphology
. 2010 Mar;
42(4):161-75.
PMID: 20218084
We sought to define the incidence, risk factors, symptoms, and quality of life (QOL) outcomes associated with various degrees of postoperative limb volume change (LVC). A prospective cohort study was...
7.
Hardy D, Liu C, Cormier J, Xia R, Du X
Ann Oncol
. 2010 Mar;
21(9):1825-1833.
PMID: 20211871
Background: The study's objective was to investigate the risks of developing cardiac disorders following the administration of chemotherapy and radiation therapy in patients with non-small-cell lung cancer (NSCLC). Methods: The...
8.
Anaya D, Lahat G, Wang X, Xiao L, Pisters P, Cormier J, et al.
Ann Oncol
. 2009 Jul;
21(2):397-402.
PMID: 19622598
Background: Current American Joint Committee on Cancer retroperitoneal sarcoma (RPS) staging is not representative of patients with RPS specifically and has limited discriminative power. Our objective was to develop a...
9.
Lahat G, Dhuka A, Lahat S, Lazar A, Lewis V, Lin P, et al.
Ann Surg Oncol
. 2009 Jun;
16(9):2579-86.
PMID: 19557478
Background: Decreased performance status, comorbidities, and disease natural history may erode enthusiasm for soft tissue sarcoma (STS) resection in elderly patients. Consequently, we evaluated the outcome of elderly patients amenable...
10.
Kim K, Eton O, Davis D, Frazier M, McConkey D, Diwan A, et al.
Br J Cancer
. 2008 Aug;
99(5):734-40.
PMID: 18728664
Metastatic melanoma cells express a number of protein tyrosine kinases (PTKs) that are considered to be targets for imatinib. We conducted a phase II trial of imatinib in patients with...